| Heading: |
Medical Treatments |
| Question ID: |
1790709 |
| UIN: |
42962 |
| House: |
Commons |
| Date tabled: |
2025-03-31 |
| Asking Member ID: |
5207 |
| Asking Member display name: |
Clive Jones
|
| Asking Member handle: |
|
| Asking Member Twitter reference: |
Clive Jones
|
| Member interest: |
false |
| Question text: |
To ask the Secretary of State for Health and Social Care, if he will make an assessment of the potential impact of the requirement for opportunity cost neutrality in the National Institute for Health and Care Excellence severity modifier on funding for tr |
| Is named day: |
false |
| Date of holding answer: |
|
| Date answered: |
2025-04-04 |
| Date answer corrected: |
|
| Is holding answer: |
false |
| Is correcting answer: |
false |
| Answering Member ID: |
4444 |
| Answering Member display name: |
Karin Smyth
|
| Answering Member handle: |
karinsmyth
|
| Answering Member Twitter reference: |
@karinsmyth
|
| Correcting Member ID: |
|
| Correcting Member display name: |
|
| Correcting Member handle: |
|
| Correcting Member Twitter reference: |
|
| Answer text: |
The National Institute for Health and Care Excellence (NICE) is responsible for developing the methods and processes that its independent committees use in their evaluations, independently and in consultation with stakeholders. The severity modifier is ba... |
| Original answer text: |
|
| Comparable answer text: |
|
| Answering body ID: |
17 |
| Answering body name: |
Department of Health and Social Care |
| Tweeted: |
true |